#tresiba

[fingerprickingood-blog]

The real reason I can’t have nice things

[sugarfreethanks-blog]

Night shot

[fingerprickingood-blog]

This is the highest I’ve been in weeks.

Usually I’m on the hypo side of the spectrum since being diagnosed and since being in my honeymoon period I’ve had relatively good levels (being between 90-120).

Tonight I didn’t really think about taking any extra insulin before eating a slice of my birthday cake and eating a baked potato and a swig of soft drink since I’ve been pretty low all day, being 90 mg/dl before eating. I was wondering why I was getting a headache so decided to take a test and BOOM! 

But being hyper doesn’t scare me as much as hypos do though. I don’t experience them often, but what I usually do if I’m high is sit in the bath for 20 minutes which will bring me down at least 50 mg/dl quickly or I’ll go for a 20-30 minute walk that will bring me down even more at a pretty steady pace (though at this point I might do both tonight to be on the safe side).

It’s times like these that proves to myself that I really am T1D and that it isn’t a huge mix up, and even though I’m in my honeymoon period I still have to think bout my choices (if it’s a special day I should still be considering the sugar content in what I’m eating and bolus for it).

P.S the cake was worth the sugar spike 

[sugarfreethanks-blog]

Studying and Tresiba time 📚🙇🏼‍♀️💉

[sugarfreethanks-blog]

My best friends ❤💉

[sugarfreethanks-blog]

Insuliiiin 💕

[littleblondesoprano]

Hey is any other diabetic having issues ordering their insulin pens? Bc I’m being told that they straight up do not have/can’t get Tresiba

[siglerprescriptiondrugcards]

Insulin Degludec

Brand Name: Tresiba

Common Dosage Forms:

Injection: 100 units/mL (U-100) and 200 units/mL (U-200) in 3 mL FlexTouch pens

FDA Indications/Dosages:

To improve glycemic control in adults with diabetes mellitus: Dosage must be individualized. Patients with type 2 diabetes who have not used insulin before should be started on 10 units per day. In diabetic patients on insulin, start with the same total daily dose of long or intermediate acting insulin.

Monitor: HbA1C, FBG, Body weight

Pharmacology/Pharmacokinetics: Insulin is the primary hormone responsible for carrying out proper glucose utilization in metabolic processes. In adipose and muscle tissue, insulin activates specific enzymes, promotes the transport of monosaccharides (including glucose) across cell membranes and facilitates the transformation of intracellular amino acids into protein. Insulin degludec is a recombinant human insulin analog that is long-acting (up to 24 hours). Insulin degludec differs from human insulin in that the amino acid threonine in position B30 has been omitted and a sidechain consisting of glutamic acid and a C16 fatty acid has been attached. The average half-life at steady state is 25 hours regardless of dosage.

Drug Interactions: The following drugs may decrease the hypoglycemic effects of insulin degludec: Corticosteroids, danazol, epinephrine and other sympathomimetic agents, oral contraceptives, thiazide diuretics, isoniazid, phenothiazines, somatropin, and thyroid hormones. The following drugs may increase the hypoglycemic effect of insulin degludec: Oral antidiabetic drugs, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, propoxyphene, salicylates, somatostatin analog, and sulfonamides.

Contraindications/Precautions: Contraindicated during episodes of hypoglycemia. Hypoglycemic reactions are not uncommon during in diabetics and may be caused by excessive insulin dose or when glucose absorption is decreased due to fasting, diarrhea, or vomiting. Hypoglycemia may be differentiated from ketoacidosis not only by lab tests but by its symptoms. Symptoms of hypoglycemia include sudden onset, sweating, headache, dizziness, confusion, shakiness, slurred speech, hunger, and a rapid pulse. Symptoms of ketoacidosis include polydipsia, polyuria, drowsiness, anorexia, breathing difficulty, fruity-smelling breath, and nausea or vomiting. Hypoglycemia may be treated with glucose tablets, orange juice, or hard candy. Insulin degludec is not intended for intravenous administration. The prolonged duration of action of insulin degludec is dependent on subcutaneous administration. Pregnancy Category C.

Adverse Effects: Adverse effects are usually mild and may include injection site reactions, lipodystrophy, weight gain, edema, nasopharyngitis, headache, upper respiratory tract infections, and diarrhea. A more potentially severe adverse effect is hypoglycemia.

Patient Consultation:

Proper dosage technique is important, and the patient should read the enclosed patient information sheet.

Leave the needle in the skin for 6 seconds after depressing the dose butting to allow time for all the medication to be released.

Follow the prescribed diet carefully and continually monitor blood or urine glucose as prescribed.

Contact a physician during any illness.

Do not dilute or mis this product with any other insulin or solution.

This product should be clear and colorless with no particles visible.

Unopened vials should be stored in the refrigerator (36°F-46°F). Do not freeze. Opened vials may be kept at room temperature (<86°F) for 56 days.

Wear or carry diabetic identification in case of emergencies.

If a dose is missed, take it as soon as possible. If it is closer to the time of your next dose than your missed dose, skip the missed dose and stay on your regular dosing schedule.

Patients should be aware of the signs of hypoglycemia including sweating, tremor, blurred vision, weakness, hunger, and confusion. When two or more of these effects are seen, treat with oral glucose or contact a physician.